Associate Professor, Pediatrics, University of Tennessee Health Science Center College of Medicine
Pediatric Hematology & Oncology
Dr. Fariba Navid, MD
|
|
Give Review
Fariba Navid works in the field of Pediatric Hematology & Oncology. He graduated from Tulane University School of Medicine. Dr. Fariba Navid is a published doctor. He published 51 publications, including: 'AP-2 may contribute to IGF-II overexpression in rhabdomyosarcoma.'
Publications
- Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in Osteosarcoma using DCE-MRI.
- Ocular abnormalities in patients treated with a novel anti-GD2 monoclonal antibody, hu14.18K322A.
- FDG PET/CT imaging of desmoplastic small round Cell tumor: findings at staging, during treatment and at follow-up.
- Pneumothorax as a complication of combination antiangiogenic therapy in children and young adults with refractory/recurrent solid Tumors.
- Influence of bony resection margins and surgicopathological factors on outcomes in limb-sparing surgery for extremity Osteosarcoma.
- Comparison of pain outcomes between two anti-GD2 antibodies in patients with neuroblastoma.
- The Genomic Landscape of Childhood and Adolescent Melanoma.
- Safety of ultrasound contrast agents in the pediatric oncologic population: a single-institution experience.
- Recurrent somatic structural variations contribute to tumorigenesis in pediatric Osteosarcoma.
- Management of Local Recurrence of Pediatric Osteosarcoma Following Limb-Sparing Surgery.
- Alternative formulations of sorafenib for use in children.
- Hypersensitivity reaction to high-dose methotrexate and successful rechallenge in a pediatric patient with Osteosarcoma.
- Erratum to: Analysis of Prognostic Factors in Extraosseous Ewing Sarcoma Family of Tumors: Review of St. Jude Children's Research Hospital Experience.
- Lack of specificity of plasma concentrations of inhibin B and follicle-stimulating hormone for identification of azoospermic survivors of childhood Cancer: a report fr...
- Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid Tumors.
- Timing of surgery and the role of adjuvant radiotherapy in ewing Sarcoma of the chest wall: a single-institution experience.
- 64Cu-p-NH2-Bn-DOTA-hu14.18K322A, a PET Radiotracer Targeting Neuroblastoma and Melanoma.
- Analysis of Prognostic Factors in Extraosseous Ewing Sarcoma Family of Tumors: Review of St. Jude Children's Research Hospital Experience.
- Dose escalation of intravenous irinotecan using oral cefpodoxime: A phase I study in pediatric patients with refractory solid Tumors.
- Jaw Dysfunction Related to Pterygoid and Masseter Muscle Dosimetry after Radiation Therapy in Children and Young Adults with Head-and-Neck Sarcomas.
- Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with Cancer.
- Caveolin-1 modulates the ability of Ewing's Sarcoma to metastasize.
- Quantitation of sorafenib and its active metabolite sorafenib N-oxide in human plasma by liquid chromatography-tandem mass spectrometry.
- Anti-GD2 antibody therapy for GD2-expressing Tumors.
- Preliminary results from a prospective study using limited margin radiotherapy in pediatric and young adult patients with high-grade nonrhabdomyosarcoma Soft-tissue sa...
- Stability of cyclophosphamide in extemporaneous oral suspensions.
- Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid Tumors: a report from the children's oncology group.
- Body wall and visceral nonrhabdomyosarcoma Soft tissue sarcomas in children and adolescents.
- Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid Tumors.
- Sperm cryopreservation practices among adolescent Cancer patients at risk for infertility.
- Immune therapies for neuroblastoma.
- Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone Sarcoma.
- Stability of sunitinib in oral suspension.
- Autocrine Transforming Growth Factor-beta Growth Pathway in Murine Osteosarcoma Cell Lines Associated with Inability to Affect Phosphorylation of Retinoblastoma Protein.
- Low Dose Histone Deacetylase Inhibitor, Depsipeptide (FR901228), Promotes Adenoviral Transduction in Human Rhabdomyosarcoma Cell Lines.
- Pulmonary nodules discovered during the initial evaluation of pediatric patients with bone and Soft-tissue sarcoma.
- Second Cancers in patients with the Ewing sarcoma family of tumours.
- Prognostic factors for local and distant control in Ewing sarcoma family of Tumors.
- Desmoplastic small round Cell tumor in childhood: the St. Jude Children's Research Hospital experience.
- Analysis of prognostic factors in ewing sarcoma family of Tumors: review of St. Jude Children's Research Hospital studies.
- A model for quantitative changes in the magnetic resonance parameters of muscle in children after therapeutic irradiation.
- Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived Cells.
- Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk Sarcomas: the St. Jude Children's Research Hospital e...
- STAT3 is activated in a subset of the Ewing Sarcoma family of tumours.
- The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma.
- Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyoSarcomagenesis.
- Immunomagnetic purging of Ewing's Sarcoma from blood and bone marrow: quantitation by real-time polymerase chain reaction.
- Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group e...
- AP-2 may contribute to IGF-II overexpression in rhabdomyoSarcoma.
- Albumin, IgG, retinol-binding protein, and alpha1-microglobulin excretion in childhood.
Schools
Tulane University of Louisiana
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
- Aetna
- Assurant Health
- Blue Card PPO
- Network S
- Bluegrass Family Health
- Great West Healthcare-Cigna PPO
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- Coventry Health Care of Tennessee PPO
- Emblem Health
- First Health (Coventry Health Care) PPO
- Golden Rule
- GEHA
- HealthPartners
- Humana
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Qualchoice PPO
- Tricare
- Navigate HMO
- United Healthcare
Education
-
National Capital Consortium -
Case Western Reserve University - University Hospitals -
Tulane University School of Medicine
Hospital
-
University of Tennessee Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Sneh A. Bhatnagar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa M. Hudson, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Wayne L. Furman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Victor M. Santana, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jeffrey E. Rubnitz, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|